BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation (original) (raw)
Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053–1064 ArticlePubMed Google Scholar
Shield K, Ackland ML, Ahmed N, Rice GE (2009) Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol 113(1):143–148 ArticlePubMed Google Scholar
Kim TH, Mount CW, Gombotz WR, Pun SH (2010) The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31(28):7386–7397 ArticlePubMedCAS Google Scholar
Grun B, Benjamin E, Sinclair J, Timms JF, Jacobs IJ, Gayther SA, Dafou D (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif 42(2):219–228 ArticlePubMedCAS Google Scholar
Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15(5):365–377 ArticlePubMed Google Scholar
Herrera B, van Dinther M, Ten Dijke P, Inman GJ (2009) Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res 69(24):9254–9262 ArticlePubMedCAS Google Scholar
Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM (2009) BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2:4 ArticlePubMed Google Scholar
Ma Y, Ma L, Guo Q, Zhang S (2010) Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res 29:85 ArticlePubMed Google Scholar
Moll F, Millet C, Noel D, Orsetti B, Bardin A, Katsaros D, Jorgensen C, Garcia M, Theillet C, Pujol P, Francois V (2006) Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. FASEB J 20(2):240–250 ArticlePubMedCAS Google Scholar
Pils D, Wittinger M, Petz M, Gugerell A, Gregor W, Alfanz A, Horvat R, Braicu EI, Sehouli J, Zeillinger R, Mikulits W, Krainer M (2010) BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment. Gynecol Oncol 117(2):189–197 ArticlePubMedCAS Google Scholar
Shepherd TG, Mujoomdar ML, Nachtigal MW (2010) Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion. J Ovarian Res 3:5 ArticlePubMed Google Scholar
Shepherd TG, Theriault BL, Nachtigal MW (2008) Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 414(1–2):95–105 ArticlePubMedCAS Google Scholar
Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW (2007) BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28(6):1153–1162 ArticlePubMedCAS Google Scholar
Dunfield LD, Dwyer EJ, Nachtigal MW (2002) TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells. Endocrinology 143(4):1174–1181 ArticlePubMedCAS Google Scholar
Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT, Donahoe PK (2010) Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci USA 107(44):18874–18879 ArticlePubMedCAS Google Scholar
Shepherd TG, Theriault BL, Campbell EJ, Nachtigal MW (2006) Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 1(6):2643–2649 ArticlePubMedCAS Google Scholar
Shepherd TG, Nachtigal MW (2003) Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 144(8):3306–3314 ArticlePubMedCAS Google Scholar
Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T (2003) Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14(7):2809–2817 ArticlePubMedCAS Google Scholar
Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400(6745):687–693 ArticlePubMedCAS Google Scholar
Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31(6):1403–1413 PubMedCAS Google Scholar
Boergermann JH, Kopf J, Yu PB, Knaus P (2010) Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. Int J Biochem Cell Biol 42(11):1802–1807 ArticlePubMedCAS Google Scholar
Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 18(15):4388–4392 ArticlePubMedCAS Google Scholar
Lamb J (2007) The Connectivity Map: a new tool for biomedical research. Nature reviews 7(1):54–60 ArticlePubMedCAS Google Scholar
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929–1935 ArticlePubMedCAS Google Scholar
Zhang SD, Gant TW (2008) A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics 9:258 ArticlePubMed Google Scholar
Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63(1):196–206 PubMedCAS Google Scholar
Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nature reviews 9(6):415–428 ArticlePubMedCAS Google Scholar
Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG (2011) Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis 33(1):49–58 ArticlePubMed Google Scholar
Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH (2006) Role of PI3 K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal 18(12):2262–2271 ArticlePubMedCAS Google Scholar
Ahmed N, Thompson EW, Quinn MA (2007) Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213(3):581–588 ArticlePubMedCAS Google Scholar
Tang MK, Zhou HY, Yam JW, Wong AS (2010) c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 12(2):128–138 PubMedCAS Google Scholar
Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250(2):231–250 ArticlePubMedCAS Google Scholar
Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J Biol Chem 282(28):20603–20611 ArticlePubMedCAS Google Scholar
Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J 20(15):4132–4142 ArticlePubMedCAS Google Scholar
Kamiya Y, Miyazono K, Miyazawa K (2010) Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction. J Biol Chem 285(40):30804–30813 ArticlePubMedCAS Google Scholar
Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE, Skubitz AP (2001) Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 159(6):2071–2080 ArticlePubMedCAS Google Scholar
Kim YJ, Sauer C, Testa K, Wahl JK, Svoboda RA, Johnson KR, Wheelock MJ, Knudsen KA (2005) Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci 118(Pt 17):3883–3894 ArticlePubMedCAS Google Scholar
Napolitano AP, Chai P, Dean DM, Morgan JR (2007) Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng 13(8):2087–2094 ArticlePubMedCAS Google Scholar
Tzanakakis ES, Hansen LK, Hu WS (2001) The role of actin filaments and microtubules in hepatocyte spheroid self-assembly. Cell Motil Cytoskeleton 48(3):175–189 ArticlePubMedCAS Google Scholar
Gamell C, Osses N, Bartrons R, Ruckle T, Camps M, Rosa JL, Ventura F (2008) BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J Cell Sci 121(Pt 23):3960–3970 ArticlePubMedCAS Google Scholar
Burleson KM, Boente MP, Pambuccian SE, Skubitz AP (2006) Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med 4:6 ArticlePubMed Google Scholar
Iwanicki M, Davidowitz R, Ng M, Besser A, Muranen T, Merritt M, Danuser G, Ince T, Brugge J (2011) Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. doi:10.1158/2159-8274.CD-11-0010 PubMed Google Scholar
Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577–584 ArticlePubMedCAS Google Scholar
Guo X, Wang XF (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19(1):71–88 ArticlePubMedCAS Google Scholar
Perez VA, Ali Z, Alastalo TP, Ikeno F, Sawada H, Lai YJ, Kleisli T, Spiekerkoetter E, Qu X, Rubinos LH, Ashley E, Amieva M, Dedhar S, Rabinovitch M (2011) BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. J Cell Biol 192(1):171–188 ArticlePubMed Google Scholar
Chen X, Liao J, Lu Y, Duan X, Sun W (2011) Activation of the PI3 K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Pathol Oncol Res 17(2):257–261 ArticlePubMed Google Scholar
Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB (2009) PI3 K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells. Prostate 69(2):168–180 ArticlePubMedCAS Google Scholar
Kang MH, Kang HN, Kim JL, Kim JS, Oh SC, Yoo YA (2009) Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol Rep 22(3):525–534 PubMedCAS Google Scholar
Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA (2010) BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3 K)/Akt pathway. Exp Cell Res 316(1):24–37 ArticlePubMedCAS Google Scholar
Langenfeld EM, Kong Y, Langenfeld J (2005) Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Mol Cancer Res 3(12):679–684 ArticlePubMedCAS Google Scholar
Davidson B, Espina V, Steinberg SM, Florenes VA, Liotta LA, Kristensen GB, Trope CG, Berner A, Kohn EC (2006) Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 12(3 Pt 1):791–799 ArticlePubMedCAS Google Scholar
Schilder RJ, Sill MW, Lee RB, Shaw TJ, Senterman MK, Klein-Szanto AJ, Miner Z, Vanderhyden BC (2008) Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 26(20):3418–3425 ArticlePubMedCAS Google Scholar